Cutera - CUTR Stock Forecast, Price & News

Cutera, Inc., a medical device company, researches, develops, manufactures, markets, and services laser and energy-based aesthetics systems for practitioners worldwide. The company offers Secret PRO, a device that utilizes fractional CO2 for skin resurfacing and radio frequency (RF) microneedling for deep dermal remodeling; truSculpt flex, a bio-electrical muscle stimulation device to treat patients at all fitness levels; excel V+, a vascular and benign pigmented lesion treatment platform; truSculpt iD, for the non-surgical body sculpting market; and Secret RF, a fractional RF microneedling system for tissue coagulation and hemostasis. It also provides enlighten platform, a laser system that is used for tattoo removal, as well as to treat benign pigmented lesions and acne scars; excel HR platform, a hair removal solution for various skin types; and xeo platform, a multi-application platform on which a customer purchases hand piece applications for the removal of unwanted hair, treatment of vascular lesions, and skin revitalization by treating discoloration, fine lines, and laxity. In addition, the company distributes skincare products; and offers post-warranty services through extended service contracts or direct billing. Further, it provides pulsed light hand pieces for the treatment of discoloration, hair removal, and vascular treatments; and Pearl and Pearl Fractional hand pieces, as well as sells hand piece refills, cycle refills, consumable tips, and marketing brochures through the company's website. The company markets and sells its products through direct sales force to plastic surgeons, dermatologists, gynecologists, family practitioners, primary care physicians, and other qualified practitioners, as well as for physicians performing aesthetic treatments in non-medical offices. Cutera, Inc. was incorporated in 1988 and is headquartered in Brisbane, California.

Cutera Price Performance

Shares of CUTR Stock traded up $1.75 during trading hours on Friday, reaching $50.70. The stock had a trading volume of 181,428 shares, compared to its average volume of 266,151. The stock's fifty day simple moving average is $41.80 and its 200 day simple moving average is $46.88. The firm has a market capitalization of $992.71 million, a PE ratio of -13.81 and a beta of 1.86. Cutera has a 12 month low of $31.62 and a 12 month high of $74.38. The company has a current ratio of 4.36, a quick ratio of 3.83 and a debt-to-equity ratio of 12.56.

Cutera (NASDAQ:CUTR - Get Rating) last posted its earnings results on Thursday, August 4th. The medical device company reported ($0.24) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.23) by ($0.01). The firm had revenue of $64.22 million during the quarter, compared to analysts' expectations of $63.42 million. Cutera had a negative return on equity of 151.43% and a negative net margin of 27.62%. The business's revenue for the quarter was up 9.6% compared to the same quarter last year. During the same quarter in the prior year, the company earned $0.39 earnings per share. On average, equities research analysts predict that Cutera will post -1.88 EPS for the current year.

Wall Street Analyst Weigh In

Several research analysts have recently weighed in on the company. StockNews.com downgraded Cutera from a "hold" rating to a "sell" rating in a research note on Thursday, May 12th. Stephens lifted their target price on shares of Cutera from $68.00 to $78.00 in a research note on Monday, May 9th. Maxim Group restated a "buy" rating and set a $80.00 price target on shares of Cutera in a research note on Friday, August 5th. Piper Sandler reduced their price objective on shares of Cutera from $65.00 to $55.00 and set an "overweight" rating for the company in a research note on Friday, August 5th. Finally, TheStreet downgraded Cutera from a "c-" rating to a "d+" rating in a research report on Thursday, July 7th.